Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...
Dr. Benjamin Jon Golas of Hackensack Meridian Health discussed the main strategies for treating pancreas cancer, focusing on ...
The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...
Researchers hope to improve survival rates through early detection with a blood test that can detect over 50 types of cancer.
MedPage Today on MSN
Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm
SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...
A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
What was once a metro Atlanta restaurateur's modest tribute to her late mother has become a multi-million-dollar philanthropy ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
Investigators from @hopkinskimmel (@wonjinho1, @DNSidiropoulos, @AmandaHuffPhD, @DrLizJaffee) create free atlas of ...
A new Brazilian study has revealed the key role of the protein periostin and stellate pancreatic cells in allowing pancreatic ...
Because 13% survival is not enough, PanCAN has set a bold goal: Drive the five-year survival rate to 20% by 2030. We will do ...
News-Medical.Net on MSN
Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results